Russell Barton
Geschäftsführer bei ACUMEN PHARMACEUTICALS, INC.
Vermögen: 309 006 $ am 30.04.2024
Profil
Mr. Russell Barton is a Director-Clinical Operations at AgeneBio, Inc., a Chief Operating Officer at Acumen Pharmaceuticals, Inc. and a President & Consultant at Pharma Sagacity Consulting LLC.
Mr. Barton was previously employed as a Chief Operating Officer by Eli Lilly & Co. He received his undergraduate degree from Illinois State University and a graduate degree from Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.01.2024 | 96 867 ( 0,16% ) | 309 006 $ | 30.04.2024 |
Aktive Positionen von Russell Barton
| Unternehmen | Position | Beginn |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Geschäftsführer | 01.04.2019 |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2019 |
| Pharma Sagacity Consulting LLC | Präsident | 01.01.2018 |
Ehemalige bekannte Positionen von Russell Barton
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Geschäftsführer | - |
Ausbildung von Russell Barton
| Illinois State University | Undergraduate Degree |
| Purdue University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
| Pharma Sagacity Consulting LLC |
